Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
第一著者: | Tear, L |
---|---|
その他の著者: | Faulkner, S |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2018
|
主題: |
類似資料
-
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
著者:: Zahra Sahraei, 等
出版事項: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
著者:: Marco Moscatelli, 等
出版事項: (2023-10-01) -
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
著者:: Johannes M. Froehlich, 等
出版事項: (2023-04-01) -
Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
著者:: Nacif Marcelo S, 等
出版事項: (2012-02-01) -
Toxicity associated with gadolinium-based contrast-enhanced examinations
著者:: Silvia Maria Lattanzio
出版事項: (2021-05-01)